SCHEMBL8307940

SCHEMBL8307940

CCOC(=O)CCc1cc(CCC(=O)OCC)cc(C(O)c2cccnc2C)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.43
CYP4A11 Q02928 2/20 0.43
LMNA P02545 3/20 0.39
CYP4Z1 Q86W10 1/20 0.39
SYK P43405 5/20 0.37
RORC P51449 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPT P10636 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
P2RY12 Q9H244 1/20 0.36
AKR1C3 P42330 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304781 0.96 PPARG (0.40) CYP4F2CYP4A11LMNACYP4Z1SYK
SCHEMBL8308677 0.95 CYP4F2 (0.39) CYP4F2CYP4A11LMNACYP4Z1SYK
SCHEMBL8304255 0.87 TBXAS1 (0.47) LMNAALDH1A1MAPT
SCHEMBL8310033 0.86 HDAC3 (0.42) LMNAMAPTHTT
SCHEMBL8308752 0.85 TBXAS1 (0.56)
SCHEMBL8308483 0.76 CYP3A4 (0.45) P2RY12
SCHEMBL8593323 0.74 CYP4F2 (0.48) CYP4F2CYP4A11LMNACYP4Z1KDM4E
SCHEMBL8309357 0.74 TBXAS1 (0.58) ALDH1A1MAPT
SCHEMBL29026089 0.73 LMNA (0.43) LMNARORCKDM4EALDH1A1HSD17B10
SCHEMBL30288171 0.73 LMNA (0.43) LMNARORCKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0579618-B1 PYRIDINE- AND IMIDAZOLE-DERIVED AGENTS FOR CARDIOVASCULAR DISEASES PFIZER LTD (GB) 1999-10-13 EP disclosed
US-5457118-A Pyridine derived agents for cardiovascular diseases PFIZER INC. (US) 1995-10-10 US disclosed